Sydney Adventist Hospital 02 9487 9111


Sydney Adventist Hospital
« View pages

Clinical Specialties

Gatrointestinal Cancer Clinical Trials

ASCENT

An Australian Translational Study to Evaluate the Prognostic Role of Inflammatory Markers in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab (Avastin™)

http://clinicaltrials.gov/ct2/show/NCT01588990


Challenge – Recruiting

A phase III study of the impact of a physical activity program on disease –free survival in patients with high risk stage II or stage III colon cancer: a randomised controlled trial

http://clinicaltrials.gov/show/NCT00819208


COTEZO 

GO 30182A Phase III, open-label, multicenter, three-arm, randomized study to investigate the efficacy and safety of cobimetinib plus atezolizumab and atezolizumab monotherapy vs. regorafenib in patients with previously treated unresectable locally advanced or metastatic colorectal carcinoma

https://clinicaltrials.gov/ct2/show/NCT02788279?term=atezolizumab+and+cobimetinib&rank=5


Doctor 

Doctor Trial Randomised phase 2 trial of pre op Cisplatin, 5FU and Docetaxel +/- radiotherapy based on poor early response to standard chemo for resectable adenocarcinoma of the oesophagus and or OG junction

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=308313


Gilead - Recruiting

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-5745 Combined with mFOLFOX6 as First Line Treatment in Patients with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

https://clinicaltrials.gov/ct2/show/NCT02545504

Back to Top

Sydney Adventist Hospital Clinical Specialties and Services